Home About ATSDR Press Room A-Z Index Glossary Employment Training Contact Us CDC  
ATSDR/DHHS Agency for Toxic Substances and Disease Registry Agency for Toxic Substances and Disease Registry Department of Health and Human Services ATSDR en Español

Search:

Primer Contents
En español
 
Preface
About the Primer
 
Principles & Techniques
 
Why Evaluate?
Types of Evaluation
Evaluation Design
Measure of Effectiveness
Barriers to Evaluation
 
Evaluation & Research
 
Designing and Testing
Review and Pretesting
Pretest Methods
Print Materials
Sample Survey
Group Case Study
Using Pretest Results
Special Populations
Risk Message Checklist
 
Outcomes & Impacts
 
Assessment Questions
Evaluation Options
Midcourse Reviews
Have We Succeeded?
Evaluation Case Example
Evaluation Action Plan
Effective Program
 
Selected References
 
Risk Documents
 
Cancer Policy
Risk Assessment
Communication Primer
Methyl Parathion
Psychologial Responses
 
ATSDR Resources
 
Case Studies (CSEM)
Exposure Pathways
GATHER (GIS)
HazDat Database
Health Assessments
Health Statements
Interaction Profiles
Interactive Learning
Managing Incidents
Medical Guidelines
Minimal Risk Levels
Priority List
ToxFAQs™
ToxFAQs™ CABS
Toxicological Profiles
Toxicology Curriculum
 
External Resources
 
CDC
eLCOSH
EPA
Healthfinder®
Medline Plus
NCEH
NIEHS
NIOSH
OSHA
 

Agency for Toxic Substances and Disease Registry (ATSDR) 
Evaluation Primer on Health Risk Communication Programs

Guidelines for Analyzing Pretest Results


(AED, JHU and PN 1993)

Remember these guidelines as you first plan, and then consider the meaning of the pretest findings.

  • Write a clear statement of purpose prior to the pretest.
    • Make sure that the questions asked relate to the purpose.
    • Then use the purpose statement to analyze the findings.
  • Consider what was found and what was not found; sometimes what is not stated by participants is very important.
  • If the answers to some questions are unclear, consider more or different types of pretesting.

[Top of Page]


Revised May 1997.